Medical/Pharmaceuticals

PanopticAI Secures Fundraising Co-Led by Alibaba Hong Kong Entrepreneurs Fund and Gobi Partners GBA to Digitise Remote Healthcare

HONG KONG, Jan. 30, 2023 /PRNewswire/ -- PanopticAI, Hong Kong's leading health and wellness monitoring startup, announced a deal closing on a seed-round funding co-led by Alibaba Hong Kong Entrepreneurs Fund (AEF) and Gobi Partners GBA (Gobi GBA), with participation from the HKUST Entrepreneursh...

2023-01-30 10:00 2811

Pfizer Launches AF Journey Website To Improve Atrial Fibrillation Health Literacy

KUALA LUMPUR, Malaysia, Jan. 27, 2023 /PRNewswire/ --  Pfizer Malaysia launched the new Atrial Fibrillation (AF) awareness website,www.afjourney.com.my , together with the National Heart Association of Malaysia (NHAM) and Malaysia Stroke Council (MSC). Atrial Fibrill...

2023-01-27 09:41 6576

DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease

SALT LAKE CITY, Jan. 27, 2023 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing cell-based regenerative therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced the U.S. Food and Drug ...

2023-01-27 08:46 2967

Malaysian Society of Plastic and Reconstructive Surgery to host extensive networking and learning event for plastic surgeons and residents

The two-day symposium will have its core focus on cosmetic breast surgery, with two live surgical demonstrations. CPD points to be given to all participating surgeons. KUALA LUMPUR, Malaysia, Jan. 27, 2023 /PRNewswire/ --  The Malaysian Society for Plastic and Reconstructive Surgery (MSPRS) is s...

2023-01-27 08:00 3521

Rainwater Charitable Foundation Announces Fourth-Annual Rainwater Prize Winners for Brain Research

Honorees are recognized for their innovative scientific discoveries for neurodegenerative diseases FORT WORTH, Texas, Jan. 26, 2023 /PRNewswire/ -- The Rainwater Charitable Foundation, one of the largest independent funders of neurodegenerative disease research, today announced this year's recip...

2023-01-26 22:00 2990

Ascletis Announces IND Approval of Oral Viral Polymerase Inhibitor ASC10 for Monkeypox Indication by China NMPA

--Preclinical studies show that ASC10-A, the active metabolite of double prodrug ASC10, has potent antiviral activities against both monkeypox and SARS-CoV-2 viruses --Ascletis has received the Notice of Issuance from the United States Patent and Trademark Office (USPTO) for the patent applicati...

2023-01-26 21:08 2960

Esaote presents the world premiere of its new MyLab™X90 ultrasound device

An innovative premium system combining outstanding performance with artificial intelligence to optimize workflows and support advanced and interconnected healthcare systems MANAMA, Bahrain, Jan. 26, 2023 /PRNewswire/ -- Today Esaote, a leading Italian company in the biomedical sector – in ultras...

2023-01-26 19:00 3033

Alma, a Sisram Medical company, announces the launch of Alma Duo - an advanced, FDA and CE approved solution that promotes sexual wellness for men and women

NURNBERG, Germany, Jan. 26, 2023 /PRNewswire/ -- Alma , one of the top three global leaders of energy-based medical and aesthetics solutions, has announced the launch of its new sexual wellness product -Alma Duo . ...

2023-01-26 17:00 2389

Fosun International Wins Platinum Award at The Asset ESG Corporate Awards 2022

HONG KONG, Jan. 26, 2023 /PRNewswire/ -- Fosun International Limited ("Fosun International" or the "Company") (HKEX: 00656) was informed byThe Asset, the renowned international asset management and investment magazine, that Fosun has garnered the Platinum Award at The Asset ESG Corporate Awards 2...

2023-01-26 14:59 3810

Daewoong Pharmaceutical submitted NDA for its global new drug Fexuclue in 11 countries, only 1 year after approval in Korea

"Expected to change GERD drug market landscape" * Application for product approval of Fexuclue, a new drug for gastroesophageal reflux disease (GERD), has been completely submitted toColombia ,Vietnam, and Saudi Arabia * NDA submissions in 11 countries completed in the shortest time among K...

2023-01-26 09:14 2405

GenKOre Announces Collaboration with a US-based Company on In vivo Gene-editing Therapy

SEOUL, South Korea, Jan. 26, 2023 /PRNewswire/ -- GenKOre, Inc., a Korea-based biotech company with hypercompact CRISPR-Cas tools, announced that it has entered into a strategic research collaboration with a US-based biopharma company for the development of in vivo  gene editing therapies. This c...

2023-01-26 09:00 2882

MedAlliance leads US Sirolimus DEB race: First US Patient enrolled into SELUTION SLR Coronary Sirolimus DEB Study

GENEVA, Jan. 26, 2023 /PRNewswire/ -- The first US patient has been enrolled at MedStar Washington Hospital Center in the SELUTION4ISR study evaluating SELUTION SLR™ to support FDA approval. This milestone follows Investigational Device Exemption (IDE) approval in the US inOctober 2022. SELUTION ...

2023-01-26 08:00 2347

Correction - Health in Transportation Releases New Smartphone Face-Scanning Application Aimed at Uncovering Potentially Serious Health Concerns in Professional Drivers

Correction Notice Please note the following corrections to the Press Release issued Jan 17, 2023 : * The CDL Health Scanner is a product of Health in Transportation. NuraLogix does not hold any liability for any applications distributed under the Health in Transportation name. * Nur...

2023-01-26 05:30 2069

Breg Partners with Correal International to Provide Orthopedic Products to Physicians & Patients in China

CARLSBAD, Calif., Jan. 26, 2023 /PRNewswire/ -- Breg, Inc., a leading orthopedic bracing and billing services company, announced today that it has partnered with medical device supplier Coreal International to bring its broad portfolio of bracing and cold therapy products to Chinese physicians an...

2023-01-26 04:54 2496

CO.DON finally saved - investor has taken over the business operations of the Leipzig-based biopharmacy company with an additional location in Teltow, Brandenburg.

CO.DON continues business operations as a GmbH (limited liability company) LEIPZIG and TELTOW, GERMANY, Jan. 26, 2023 /PRNewswire/ -- With effect from 20.01.2023, CO.DON's business activities will be continued in the legal form of a GmbH (limited liability company) following a transferring reorga...

2023-01-26 01:30 2119

PlumCare RWE partners with Lifebit on Greece's newborn genomic sequencing program, BeginNGS

* PlumCare RWE and Lifebit enter a three-year partnership to support Greece's pioneering national newborn genomic sequencing program, BeginNGS. * Researchers will be able to access and analyse data securely in combination with global cohorts, whilst ensuring data is kept safe, private and in p...

2023-01-25 23:00 2730

Malaysia Healthcare Partners with AirAsia

Cambodian Passengers Can Kickstart 2023 with Wellness Travel to Malaysia PHNOM PENH, Cambodia, Jan. 25, 2023 /PRNewswire/ -- In its pursuit to providing accessible preventive healthcare and wellness options for global citizens, Malaysia Healthcare Travel Council (MHTC) partners with AirAsia, off...

2023-01-25 14:05 2821

DiscGenics Announces Positive Two-Year Clinical Data from U.S. Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease

Discogenic progenitor cell therapy safely increased disc volume and provided rapid, durable improvements in low back pain, function, quality of life, and pain medication usage out to two years post-injection in patients with lumbar DDD. SALT LAKE CITY, Jan. 25, 2023 /PRNewswire/ -- DiscGenics, I...

2023-01-25 08:35 2219

Metabolon Secures $25 Million of Funding to Accelerate Growth

MORRISVILLE, N.C, Jan. 24, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of research, diagnostic, therapeutic development, and precision medicine applications, today announced that it has closed on$25 million of additional ...

2023-01-24 21:07 2151

Ferronova secures A$11 million to advance nanotech image-guided cancer therapy

ADELAIDE, Australia, Jan. 23, 2023 /PRNewswire/ -- Australian biotech company Ferronova announced today it has secured a furtherA$11 million to progress the company's nanoparticle platform to assist surgeons to more accurately locate and remove malignant cells during treatment of gastrointestinal...

2023-01-23 05:00 5593
1 ... 93949596979899 ... 382